DI-Leu16-IL2 Immunocytokine

A recombinant fusion protein consisting of de-immunized and humanized anti-CD20 monoclonal antibody Leu16 fused to human cytokine interleukin-2 (IL2) with potential antineoplastic activity. The antibody moiety of DI-Leu16-IL2 immunocytokine binds to tumor cells expressing the CD20 antigen, which may result in an antibody-dependent cell-mediated cytotoxicity (ADCC) towards CD20-expressing tumor cells; the localized IL2 moiety of this fusion protein may stimulate natural killer (NK) and T-lymphocyte mediated immune responses, enhancing the ADCC response. De-immunization involves the modification of potential helper T cell epitopes that bind to MHC class II molecules; humanization involves combining recombinant murine variable (V) regions with human immunoglobulin light and heavy chain constant regions. CD20 antigen, a hydrophobic transmembrane protein located on normal pre-B and mature B lymphocytes, is overexpressed by various cancer cell types. (NCI Thesaurus)

YOU MAY ALSO LIKE

Di-dgA-RFB4 Immunotoxin

An immunotoxin of monoclonal antibody (MoAb) RFB4 covalently linked to two deglycosylated ricin toxin A-chain (Di-dgA). This agent can be extracted from…

di-dgA-RFB4

An anticancer drug that is a combination of a monoclonal antibody (RFB4) and an immunotoxin (dgA).

Di Guglielmo Syndrome

The progression of a myelodysplastic syndrome in which there is erythroid predominance into erythroleukemia (M6a or erythroleukemia, erythroid/myeloid).

DHX16 wt Allele

Human DHX16 wild-type allele is located in the vicinity of 6p21.3 and is approximately 20 kb in length. This allele, which encodes…

DHX16 Gene

This gene plays a role in RNA splicing.

DHT

A hormone made from testosterone in the prostate, testes, and certain other tissues. It is needed to develop and maintain male…